Amerisource acquires Bellco Health
Executive Summary
AmerisourceBergen will purchase branded and generic pharmaceuticals distributor Bellco Health for $235 million, the company announces March 28. Bellco, headquartered in New York, has annualized revenues of $2 billion. AmerisourceBergen CEO David Yost said Bellco's nationwide sales of dialysis products and services complement his company's specialty distribution business. AmerisourceBergen expects earnings from the acquisition to be neutral in the first year and slightly accretive by the second year. The acquisition is expected to close during the second quarter...